Dr. Gérard Ber released an open letter to stockholders of Progenics Pharmaceuticals, Inc. on behalf of himself and the four other fully-independent director candidates – Dr. Eric J. Ende, Ann MacDougall, Heinz Mäusli and David W. Mims – nominated by Velan Capital, L.P. for election to the Progenics Board of Directors.
October 24, 2019
· 6 min read